Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Theravance Biopharma (TBPH) and Align Tech (ALGN)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on HeartFlow, Inc. (HTFL – Research Report), Theravance Biopharma (TBPH – Research Report) and Align Tech (ALGN – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
HeartFlow, Inc. (HTFL)
Canaccord Genuity analyst William Plovanic maintained a Buy rating on HeartFlow, Inc. yesterday and set a price target of $40.00. The company’s shares closed last Monday at $28.78.
According to TipRanks.com, Plovanic is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for HeartFlow, Inc. with a $38.50 average price target, a 30.1% upside from current levels. In a report issued on January 28, Wells Fargo also initiated coverage with a Buy rating on the stock with a $38.00 price target.
See the top stocks recommended by analysts >>
Align Tech (ALGN)
Piper Sandler analyst Jason Bednar maintained a Buy rating on Align Tech today and set a price target of $200.00. The company’s shares closed last Monday at $163.63, close to its 52-week low of $157.57.
According to TipRanks.com, Bednar is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Align Tech is a Moderate Buy with an average price target of $185.00, a 13.6% upside from current levels. In a report issued on January 19, TipRanks – Google also upgraded the stock to Buy with a $191.00 price target.
